ADTX (ADTX) Stock Price & Analysis
ADTX (ADTX) rose 0.00% to USD 0 as of July 25, 2026 at 04:37 UTC, according to Nexqual real-time market data.
ADTX last closed at USD 0; the session ranged USD 0–0 on volume of 4,892,754 shares. Market capitalization is —, with a 52-week range of USD 0–31,364.28 (PNK). Source: Nexqual, July 25, 2026 at 04:37 UTC.
Key Statistics (as of July 25, 2026 at 04:37 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 31,364.28 |
| Volume | 4,892,754 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (ADTX)
Nexqual's technical model rates ADTX "SELL" based on 1 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 04:37 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 32.23 (neutral) |
| vs SMA50 | Below (USD 0.27) |
| MACD | -0.29 (negative) |
From ADTX's Latest SEC 10-K Filing (filed 2026-03-31)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ENSC | Ensysce Biosciences, Inc. | USD 0.26 | ▼ 7.96% |
| RKTO | Rocket One Inc. | USD 0.79 | ▼ 4.35% |
| ADIL | Adial Pharmaceuticals, Inc | USD 2.78 | ▲ 2.96% |
| DBGI | Digital Brands Group, Inc. | USD 12.9 | ▼ 35.63% |
| PALI | Palisade Bio, Inc. | USD 1.95 | ▲ 2.63% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:37 UTC. This page is informational and not investment advice.